Topics

Roche's $4.8 Billion Acquisition of Spark Pushed Back to April 2020 http://dlvr.it/R84wD2 pic.twitter.com/V3mTtU9Sh6

10:38 EDT 9 Jul 2019 | Biotechnology Twitter

Roche's $4.8 Billion Acquisition of Spark Pushed Back to April 2020 http://dlvr.it/R84wD2 

Original Article: Roche's $4.8 Billion Acquisition of Spark Pushed Back to April 2020 http://dlvr.it/R84wD2 pic.twitter.com/V3mTtU9Sh6

NEXT ARTICLE

More From BioPortfolio on "Roche's $4.8 Billion Acquisition of Spark Pushed Back to April 2020 http://dlvr.it/R84wD2 pic.twitter.com/V3mTtU9Sh6"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...